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Since the emergence of the 2009 pandemic (H1N1) virus (2009/H1N1) in April 2009, cases of transmission from
humans to pigs have been reported frequently. In our previous studies, four 2009/H1N1 variants were isolated from
pigs. To better understand the phenotypic differences of the pig isolates compared with the human isolate, in this
study mice were inoculated intranasally with different 2009/H1N1 viruses, and monitored for morbidity, mortality,
and viral replication, cytokine production and pathological changes in the lungs. The results show that all isolates
show effective replication in lungs, but varying in their ability to cause morbidity. In particular, the strains of
A/swine/Nanchang/3/2010 (H1N1) and A/swine/Nanchang/F9/2010 (H1N1) show the greatest virulence with a
persisting replication in lungs and high lethality for mice, compared with the human isolate A/Liaoning /14/2009
(H1N1), which shows low virulence in mice. Furthermore, the lethal strains could induce more severe lung
pathological changes and higher production of cytokines than that of other strains at an early stage. Amino acid
sequence analysis illustrates prominent differences in viral surface glycoproteins and polymerase subunits between
pig isolates and human strains that might correlate with their phenotypic differences. These studies demonstrate
that the 2009/H1N1 pig isolates exhibit heterogeneous infectivity and pathogencity in mice, and some strains
possess an enhanced pathogenicity compared with the human isolate.Introduction
The 2009 pandemic H1N1 influenza virus (designed
2009/H1N1) emerged in April 2009, rapidly spreading in
human populations, and developing into the first pan-
demic virus of the 21st century [1]. Though the world is at
the post-pandemic period, 2009/H1N1 virus might pose a
potential threat to humans or animals. Epidemiological or
serological surveillances identifying the 2009/H1N1 virus
in pigs show that it is still on the rise. The first case of
2009/H1N1 infection in pigs was reported in a commer-
cial swine herd in Alberta, Canada, and the pigs subjected
to the 2009/H1N1 pig isolates recovered relatively quickly
compared with those infected with 2009/H1N1 isolates
from humans [2]. Subsequently, the natural infection of
pigs with 2009/H1N1 has been reported in more than 10
countries, including China [3,4], Thailand [5], South Korea* Correspondence: jinmeilin@mail.hzau.edu.cn
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reproduction in any medium, provided the or[6], United Kingdom and others [7,8]. When compared
with the sequences of the representative A/California/04/
2009 strain (CA/04), the protein sequences of these pig
isolates display different amino acid mutations, though
they share high homology with those of CA/04 [4,9,10].
More importantly, what should be taken into account is
that novel viruses have been generated by the reas-
sortment of 2009/H1N1 with other influenza virus strains
circulating in pig populations [11-13], which further con-
firms the potential threat of 2009/H1N1 to public health.
To date, numerous studies have addressed the patho-
genesis of 2009/H1N1 in animal models, including mice
[14-16], ferrets [16,17], guinea pigs [18], monkeys [15] and
others [19,20]. For instance, the representative CA/04
strain replicates efficiently in nonhuman primates and
replicates without clinical symptoms in specific-pathogen
free miniature pigs [15]. In the mice model, studies on the
infectivity of different 2009/H1N1 isolates show high virus
titers on 3 days post infection (dpi) and a slight decrease
on 6 dpi in lung tissues although the decrease varies
among strains [15,16]. Many investigators have concen-
trated on the pathogenicity of 2009/H1N1 isolates in a
mice model, and found that most of the tested 2009/his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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highest dose of 106.5EID50 or PFU, though they could
cause more severe pathological lesions in lungs than cur-
rently seasonal A(H1N1) viruses [14,15,21,22]. Most strik-
ingly, researchers recently isolated some 2009/H1N1
variants with certain amino acid mutations, and infection
experiments showed that these variants could induce ap-
proximately 40%-100% lethal response in mice even at the
lower doses [10,23,24], which indicates that 2009/H1N1
viruses possess a potential phenotypic variability in the
evolutionary process.
In our previous studies, four novel 2009/H1N1 viruses
were isolated from pigs and primary experiments showed
the strains could cause systemic infection in mice, and
two strains could induce predominant lethal response in
mice, indicating the possibly enhanced pathogenicity of
these isolates [4]. Nevertheless, the characterization of
these 2009/H1N1 pig isolates in a mice model remains
largely unknown. To better understand the comparative
pathogenesis of 2009/H1N1 pig isolates compared with
the human isolate, in the present study, systematic experi-
ments in a mice model were performed to evaluate the
infectivity and pathogenicity of these novel strains, and to
further investigate the pathological changes in the lungs
and cytokine responses induced by these isolates in com-
parison with a 2009/H1N1 human isolate. The findings
demonstrate that 2009/H1N1 pig isolates exhibit hetero-
geneous infectivity and pathogencity in mice, and some




The influenza A viruses used in this study are shown
in Table 1. The four novel viruses were isolated from
pigs in our clinical surveillances and conserved at −80°C.
A/swine/Nanchang/3/2010 (H1N1) (3/10), A/swine/Nan-
chang/5/2010 (H1N1) (5/10), and A/swine/Nanchang/6/
2010 (H1N1) (6/10) were isolated from tracheal mucus of
pigs at the age of about 50 days. A/swine/Nanchang/F9/
2010 (H1N1) (F9/10) was isolated from the lung tissue ofTable 1 2009/H1N1 Influenza viruses used in this study
Influenza virus strains Name in study Gen
A/swine/Nanchang/3/2010 (H1N1) 3/10 JF27591
A/swine/Nanchang/5/2010 (H1N1) 5/10 JF27593
A/swine/Nanchang/6/2010 (H1N1) 6/10 JF27594
A/swine/Nanchang/F9/2010 (H1N1) F9/10 JF27592
A/Liaoning /14/2009(H1N1) LN/09 KC68349
aThe 50% mouse lethal dose (MLD50) was determined by intranasally inoculating gr
50 μL and calculated by the method of Reed and Muench [25].
bNC indicates the MLD50 of the strains could not be counted due to low mortality opigs that showed mild or asymptomatic respiratory signs.
Genome sequencing of the four viruses showed that they
exhibited more than 99% homology to sequences of CA/
04 [4]. A/Liaoning/14/2009 (H1N1) (LN/09) was isolated
from the nasal swab of a patient with influenza-like symp-
toms. All viruses were propagated in Madin-Darby canine
kidney (MDCK) cells grown in DMEM supplemented with
10% fetal bovine serum, 1% penicillin-streptomycin and
TPCK trypsin (1 μg/mL) (Gibco, Karlsruhe, Germany).
The second passage of each virus was used in the following
mice experiments. The viral titer was determined by a 50%
tissue culture infectious dose (TCID50) assay in MDCK
cells according to the standard methods [25].
Mice infection studies
All experiments with mice were performed according to
protocols approved by Biological Studies Animal Care
and Use Committee in Hubei province, China (approval
number: SCXK 2008–0004).
Six-week-old specific-pathogen-free female BALB/c
mice were obtained from the Institute of Laboratory
Animal Sciences, Wuhan, China. The mice were lightly
anesthetized in a chamber with isoflurane and inoculated
intranasally with the virus. The 50% mouse lethal dose
(MLD50) was determined by intranasally inoculating
groups of ten mice with serial 10-fold dilutions of each
virus in a final volume of 50 μL. In a separate experiment,
12 mice were infected with 103TCID50 (50 μL) of each
virus. Body weight and survival percents were monitored
daily for 14 days and mice with body weight loss of more
than 25% of initial body weight were humanely euthanized
with quick cervical dislocation. Six mice in each group
were euthanized respectively on 3, 5, 7 and 9 dpi to obtain
lung tissues for subsequent quantification of cytokines
and pathological investigations. Lungs collected for path-
ology were inflated with 10% neutral-buffered formalin. In
order to determine viral titers in the lungs of infected
mice in a dose dependent manner, mice were infected
with varying concentrations (102 to 105 TCID50) of each
virus and sacrificed on 3 and 6 dpi respectively. All animal
experiments with 2009/H1N1 viruses were conducted inBank ID Source TCID50 MLD50
a
7-JF275924 Tracheal mucus 10-5.5 103TCID50
3-JF275940 Tracheal mucus 10-3.2 NCb
1-JF275948 Tracheal mucus 10-4.4 NC
5-JF275932 Lung tissue 10-4.48 102.98TCID50
2-KC683499 Nasal swab 10-5.5 NC
oups of ten mice with serial 10-fold dilutions of each virus in a final volume of
r no lethality for mice.
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Chinese Ministry of Agriculture.Tissue virus load
In order to detect virus replication in lung tissues of
mice infected with 103TCID50 (50 μL) of each virus, the
lungs of mice were homogenized in 1 mL cold PBS and
the exact virus titers were determined using clarified tis-
sue homogenates in 10-day eggs from initial dilutions of
1:10, following serial titration. Fifty percent egg infec-
tious dose (EID50) titer for egg-grown stocks was calcu-
lated by the method of Reed and Muench [25]. The
mean viral titers were determined on 3 and 6 dpi,
respectively. To determine viral titers in the lungs of
infected mice in a dose dependent manner, total RNA of
the lungs was extracted with Trizol reagent (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s in-
structions, and then treated with RQ1 RNase-Free
DNase (Promega, Madison, USA) to remove potential
genomic DNA contamination. Reverse transcription and
quantitative real time PCR was performed using univer-
sal U12 primer for viral RNA (vRNA) and NP primers
(Forward: CAGGAAACGCTGAGATTGAA and Reverse:
TGGGTTTTCATTTGGTCTCA) designed in the con-
served region of the NP gene, respectively [26]. Absolute
quantitative values were calculated using a standard curve
which was generated by ten-fold serial dilutions of stand-
ard plasmid harboring NP gene of 2009/H1N1 virus. PCR
were done in triplicate to guarantee the reproducibility of
amplification of the cDNA sample.
Histopathological analysis
Grossly evident pulmonary changes were visually esti-
mated based upon the percent of virus-affected lesions in
each lung lobe as described previously [27]. For histo-
pathological analysis, mice lungs were removed immedi-
ately following euthanasia, inflated and fixed with 10%
neutral buffered formalin overnight at 4°C. Subsequently,Table 2 The amino acid mutations in the proteins of the 2009
Strains PB2 PA HAc
588 70 547 103 145 193
CA/04a T A D D S L
LN/09 T A D D S L
3/10 Ib V E E P L
5/10 I V E E P L
6/10 I V E E P Id
F9/10 I V E E P I
aThe complete genomic sequences for the referent strain A/California/04/2009 are a
1-FJ966086.1. The genomic sequences of strains used in this study are in the GenBa
bItalics show the common mutations of 2009/H1N1 pig isolates compared with the
cThe HA protein sequence is shown with the 17 amino acids of signaling peptide se
dBold letters indicate the mutations between the 2009/H1N1 pig isolates.the formalin-preserved lung samples were embedded in
paraffin and sectioned. Serial 4-mm sections were stained
with Hematoxylin and Eosin (H&E), and examined for
pathological changes corresponding to infection. Images
were obtained on an Olympus BX-50 light microscope at
10- or 50-fold original magnification.
Cytokine assays
On 3, 5, 7 and 9 dpi respectively, the lung homogenates
from mice inoculated with each virus were prepared to
measure the production of IL-6, IL-10, IL-12 (p40), IL-1β,
IFN-γ and TNFα by enzyme-linked immunosorbent assay
(ELISA) according to the manufacturer’s protocol
(Dakewe, Shenzhen, China). Each test had three replicates.
Sequence analysis
DNA sequences were combined and edited using the
Lasergene sequencing analysis software (DNASTAR,
Madison, WI, USA). Multiple sequence alignments were
performed by DNAMAN software (Version 5.2.2. Lynnon
BioSoft, USA). A/California/04/2009(H1N1) was chosen
as the referent strain (Table 2).
Statistical analysis
All experiments were reproducible and carried out in
triplicate or quadruplicate. Each set of experiments was
repeated at least three times. Statistical analyses were
done by one-way ANOVA with Bonferroni multiple
comparison test to compare each group of virus with
the others using GraphPad Prism version 5 (GraphPad
Software Inc., La Jolla, CA, USA). P values of < 0.05 were
considered to indicate a statistically significant difference
between different groups.
Results
Characterization of 2009/H1N1 viruses in mice
As mentioned above, extensive studies have indicated
that most 2009/H1N1 isolated at the early stage had low
virulence for mice except infection at higher viral doses/H1N1 pig isolates
NP NA NS1
239 34 100 344 106 248 123
D G V S V N I
D G V S V N I
D G I S I D V
D S I S I D V
D G I S I D V
G G I L I D V
vailable in the GenBank database under accession numbers FJ966079.
nk database and the accession numbers are shown in Table 1.
human strains.
quences at the N-terminal.
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6EID50 or PFU). To understand the lethal
characteristics in mice of the 2009/H1N1 pig isolates, in
this study, we determined the MLD50 for each of the vi-
ruses with 10 mice in each group and found that only 3/
10 and F9/10 could induce mortality in mice with simi-
lar MLD50 (10
3TCID50). The human isolate LN/09 did
not cause a lethal infection in mice at varying concentra-
tions, which displayed only transient weight reduction
until 7 dpi (Table 1). Therefore, we determined the body
weight loss and survival percents of mice, and virus ti-
ters in the lungs of mice at 103TCID50 of each virus.
The results show that in contrast to the LN/09, the pig
isolates, particularly, 3/10 and F9/10 demonstrate rela-
tively effective infection in mice without prior adaptation
and all the mice infected with 3/10 and F9/10 died
within 10 dpi (Figure 1A). The virulence of F9/10 was
the most prominent and challenge with F9/10 led to
nearly 30% body weight loss of initial body weight on 9
dpi. Similarly, mice inoculated with 3/10 suffered more
than 20% loss of initial body weight on 9 dpi, whereasFigure 1 Weight loss and mortality of mice inoculated with
different 2009/H1N1 virues in mice. Six-week-old BALB/c mice
were inoculated intranasally with 103TCID50 viruses, with 10 mice per
group. The mice that lost 25% of its preinoculation body weight
were humanely euthanized with quick cervical dislocation and the
data were expressed as the survival percentage of mice infected
with 103TCID50 viruses (A). Body weight of mice infected with of
each virus was measured for 14 dpi (B).the body weight loss of mice infected with 5/10, 6/10
and LN/09 was less than 20% all the time (Figure 1B).
To investigate the replication differences of each virus in
mice, we determined the virus titers in the lungs from
three inoculated mice at 103TCID50 in each group. The
results show that mice inoculated with the 3/10 and F9/10
viruses possessed significantly higher titers than those of
other viruses. The 5/10, 6/10 and LN/09 viruses were
detected in the lungs with comparable titers on 3 and 6
dpi (Data not shown). To further determine lung virus ti-
ters in a dose dependent manner, we titrated lung homog-
enates of mice infected with dose series of the viruses
(102-105 TCID50) by absolute quantitative PCR on 3 and 6
dpi respectively. After data analysis, it was found that the
virus titers on 3 dpi were higher than those on 6 dpi, al-
though the decrease of titers varied among strains on 6
dpi. Similarly, the viral titers of 3/10 and F9/10 in lungs
were still significantly higher than those of other viruses,
regardless of the infection doses and times (Figure 2). The
above observations confirmed that 3/10 and F9/10 possess
a higher replication than the other viruses. To sum up,
both 3/10 and F9/10 could be highly lethal to mice, indi-
cating a characteristic of higher infectivity and virulence
than that of the human LN/09 isolate.
Histological pathology observed in virus infected mice
The macroscopic lesions estimated visually suggest that
F9/10 infected-mice lungs exhibited the most robust
pathophysiology, including dominant pneumonia with in-
creased lung elastance and severe edema formation, with
lesions occurring in 100% lung tissue sections on 3 and 5
dpi. In addition, mice inoculated with the 3/10 virus
exhibited pathological changes in more than 75% tissue
sections on 5 dpi. Moreover, mice infected with 5/10 and
6/10 were associated with lesion occurrence in 20%-40%
of lung on 5 dpi. However, mice inoculated with LN/09
virus displayed the mildest pathology (data not shown). In
order to examine the microscopic pathological changes in
the lungs of mice challenged with different viruses, lung
tissues were isolated for HE staining on 3, 5 and 7 dpi re-
spectively. The results show that most of the lungs of mice
infected with pig isolates exhibited characteristic path-
ology of influenza infection, including inflammatory hype-
raemia, hemorrhage, edema, and exudative pathological
changes. An additional figure file shows the lung patho-
logical changes in more detail (see Additional file 1). On 5
dpi, 3/10-infected mice lungs show acute interstitial pneu-
monia with infiltration of large amounts of lymphocytes
(arrow a) and atelectasis (arrow b), in accordance with the
dyspnea and high mortality of infected mice. Similarly, F9/
10-infected mice lungs show acute pneumonia with alveo-
lar wall thickening, large amounts of infiltration of inflam-
matory cells and bleeding (arrow c). Relatively, 5/10 and
6/10 induced pathological changes of the lungs just show
Figure 2 Comparison of the viral replication in mice of
different 2009/H1N1 strains in a dose dependent manner. Five
mice of each group were infected with a dose series of the viruses
(102-105 TCID50), euthanized at 3 and 6 dpi and the titers in lung
homogenates of mice were determined using absolute quantitative
PCR on 3 (A) and 6 dpi (B) respectively. The values were calculated
through a standard curve which was generated by ten-fold serial
dilutions of standard plasmid harboring NP gene of 2009/H1N1
virus. The results are presented as mean ± SEM of virus copy
numbers. × indicates the infection dose in the groups exceeds the
content of the original virus. ND means the virus could be not
detected. Significant differences were observed at 3/10 and F9/10
compared with 5/10, 6/10 and LN/09 (* p < 0.05).
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udate (arrow e). However, LN/09-infected mice show only
slight alveolar wall thickening in lung lesions (arrow f)
(Figure 3). Collectively, 2009/H1N1 pig isolates could cause
severe macroscopic lesions and microscopic pathological
changes in the lungs of mice compared to the human
isolate.Cytokine production following infection with 2009/H1N1
viruses in mice
To determine the inflammatory cytokine production in-
duced by 2009/H1N1 viruses, lungs from mice infected
with 103TCID50 of the viruses were collected on 3, 5, 7
and 9 dpi, and homogenates were subsequently assayed
by ELISA for IL-1β, IL6, IL10, IL12, TNFa and IFN-γ.
Among the assayed cytokines, IL-1β, IL6 and TNFa in
the lungs of virus-infected mice were up-regulated
greater than constitutive levels on 3 and 5 dpi. However,on 7 and 9 dpi, IL-1β, TNFa, IL10 and IL12 in infected
mice were not significantly different from those in con-
trol mice, except that IL6 and IFN-γ were still higher in
infected mice. Although the extent of cytokine induction
varied among the strains, there remained some specific
characteristics of virus induced cytokine profile. Firstly,
in 3/10-infected mice, the production of IL-1β was
significantly higher than that of other viruses on 3 and 5
dpi. Secondly, on 5 dpi, IL6 and TNFa were highly in-
creased in F9/10-infected mice compared with other
virus-infected mice. In addition, the level of IFN-γ induc-
tion was higher in mice infected with 3/10 on 7 and 9
dpi. On 5 dpi, the levels of most cytokines except IFN-γ
were higher in F9/10-infected mice than other virus-
infected mice, and IL6 was the highest in F9/10-infected
mice on 7 dpi. In addition, the 5/10 virus only slightly
stimulated the production of IL10 on 5 dpi without pre-
dominant changes of other cytokines. In the lungs of 6/10-
and LN/09-infected mice, only IL10 induction was
relatively higher than that of other viruses. By comparison,
the pig isolates, 3/10 and F9/10 could induce higher
productions of proinflammatory cytokine TNFa, IL6 and
IL-1β than that of the human isolate LN/09 (Figure 4). In
summary, most of the proinflammatory cytokines in mice
infected with the virulent isolates with lethal characteris-
tics for mice were elevated sharply, and maintained for a
longer time.Amino acid sequence analysis
Although there is the absence of known virulence
markers in 2009/H1N1 virus, such as lysine (K) residue
at 627 in PB2 and the multi-basic cleavage site in he-
magglutinin (HA), as well as truncated PB1-F2 and NS1
proteins [28], sequence analysis reveals that several com-
mon amino acid mutations were found in six protein
segments of the four pig isolates based on the sequences
of human isolates. In particular, most amino acid differ-
ences were presented at the surface glycoproteins of
hemagglutinin (HA) and neuraminidase (NA), e.g., S145P
mutations in HA and V146I in NA, and polymerase sub-
units, e.g., A70V and D547E mutations in the PA protein
and T588I in PB2 (italics in Table 2). Sequence compari-
son among the four pig isolates revealed that F9/10 dif-
fered from other viruses at three positions, L193I, D239G
in HA (also called 176 and 222 sites by deleting signaling
peptide sequences) and S344L in NP. The strains of 5/10
and 6/10 had only one mutation at G34S in NP and L193I
in HA respectively (bold letters in Table 2). Animal exper-
iments have already shown that 3/10 and F9/10 are more
virulent than 5/10 and 6/10 due to efficient viral replica-
tion. Possibly, these amino acid residues in NP and HA
protein have an important role in the virulence of these
novel 2009/H1N1 viruses.
Figure 3 Comparison of Lung pathology in mice infected with different H1N1/2009 viruses on 5 dpi. In 3/10-infected mice lungs, signs of
acute interstitial pneumonia with infiltration of large amount of lymphocytes (arrow a) and atelectasis (arrow b) were present. Lung tissues in
lesion areas of F9/10-infected mice show acute pneumonia with alveolar wall thickening, large amounts of infiltration of inflammatory cells and
bleeding (arrow c). The pathological changes of lung tissues infected with 5/10 and 6/10 viruses just show certain alveolar wall thickening (arrow
d) and bronchial exudates (arrow e). LN/09-infected mice only show slight alveolar wall thickening in lung lesions (arrow f). Images were
obtained on an Olympus BX-50 light microscope at 50-fold original magnifications (50×).
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Many studies have explored the prevalence of 2009/H1N1
viruses isolated from pig populations worldwide. The
strains from different cases display a significant diversity
of pathogenesis in pigs [2,9,19]. Recently, researchers
compared the pathogenesis of two 2009/H1N1 viruses,
one derived from humans and another from pigs, with a
classical swine influenza virus in a pig model. Their stud-
ies confirmed that pigs are susceptible to either the swine
or human 2009/H1N1 isolates with clear symptoms and
an early increase of proinflammatory gene expression [9].
Mice have shown promising potential for elucidating the
basic viral pathogenesis of influenza virus. Nevertheless,
the comparative research on the pathogenicity and host
response of 2009/H1N1 human and pig isolates in the
mice model remains largely unknown. To explore this, in
this study, mice were inoculated intranasally with the
viruses, monitored for body weight loss, morbidity and
mortality, and measured for viral replication and cytokine
response differences in the lungs. Here, we report that the2009/H1N1 pig isolates possessed heterogeneous patho-
genicity in mice, and the strains of 3/10 and F9/10 could
cause high mortality for mice and induce high cytokines
in mice lungs compared with the human isolate. However,
5/10 and 6/10 only induced milder manifestations and
lower cytokine production in mice with lower mortality
than 3/10 and F9/10. Furthermore, mice inoculated with
the human isolate LN/09 exhibited the mildest disease
and no casualty of mice was found. The histological path-
ology in the lungs of 3/10- and F9/10-infected mice, which
was consistent with the disease outcomes, exhibited the
most severe pathological changes, compared to those in-
duced by other viruses.
Generally, disease or death due to influenza virus infec-
tion depends on host and viral factors [29]. In terms of
host factor, overproduction of cytokines such as TNFa,
IL6 and IL8 can result in severe inflammation, such as ex-
cessive recruitment of neutrophils and mononuclear cells
at the sites of infection, which has been considered to be
the basis for the clinical and pathological manifestations
Figure 4 Cytokine production of lungs in BALB/c mice infected with different H1N1/2009 viruses. On 3, 5, 7 and 9 dpi respectively, the
lung homogenates from mice inoculated with the four 2009/H1N1 pig isolates (3/10, F9/10, 5/10 and 6/10), a human isolate designed LN/09 and
control mice were prepared and tested for the production of cytokines IL-1β, IL-6, IL-10, IL-12 (p40), TNFα and IFN-γ by ELISA assay. The results
are presented as mean ± SD (n = 3) of protein levels.The statistical analysis at each time point was performed compared to data for LN/09 virus or
other viruses with lower cytokine levels (* p < 0.05).
Li et al. Veterinary Research 2013, 44:41 Page 7 of 9
http://www.veterinaryresearch.org/content/44/1/41of the disease [30]. Previous studies have indicated that
during severe high pathogenic avian influenza virus infec-
tions, increased expression of proinflammatory mediators
and reduced expression of anti-inflammatory mediators in
the lungs of hosts correlates closely with severe disease
and lethal outcome [31]. For instance, IL-6, a cytokine
involved in the induction of fever and the acute phase re-
sponse has been reported to be correlated with the relative
severity of clinical signs in ferrets infected with seasonal
H1N1 or H3N2 viruses [32]. In the studies presented here,
we used different 2009/H1N1 strains to study the time-
course host cytokine responses in a controlled experimen-
tal setting, and demonstrate strain-specific or commondifferences in the induction of inflammatory responses of
these viruses. The strains with lethal characteristics, 3/10
and F9/10 could induce higher productions of TNFa and
IL-1β than other viruses. Moreover, F9/10 possessed the
ability of inducing high expression of IL6 on the long term
of infection (Figure 4). In addition, many studies have con-
firmed that influenza virus uses multiple mechanisms to
attenuate the host anti-viral response, allowing for suc-
cessful infection [33]. In the present study, IFN-γ, as a sig-
nificant cytokine involved in host defense, was induced at
a low level by 3/10 on 3 and 5 dpi and increased only at
the late stage of infection, which was consistent with se-
verely pathological changes of the corresponding mice.
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kine IL10 was relatively low at the early time of infection
in the lethal strain-infected mice compared with that in
other viruses infected mice [34]. These results indicated
that severely pathological changes in 3/10 and F9/10
infected mice may be partly attributed to the higher ex-
pression of pro-inflammatory cytokine and lower produc-
tion of anti-viral and anti-inflammatory cytokine, though
more cytokines need to be investigated in an additional
study. In conclusion, the cytokine profiles of mice in
response to different viruses may contribute to the differ-
ent clinical progression and disease outcomes.
In terms of the viral factor, in order to identify a possible
correlation between sequence differences and virus patho-
genicity in mice, we searched for amino acid mutation
between these four pig isolates and human isolates. The
pig isolates possessed several common amino acid muta-
tions as shown in Table 2. Although the difference of
amino acids did not match the known functional sites as-
sociated with pathogenicity in mice, these novel viruses
possessed six common amino acid changes in HA, PA,
PB2 and NS1 proteins compared with human 2009/H1N1
strains. Some of the above mutations were similar to the
molecular changes of 2009/H1N1 virus reported by other
researchers [23,35]. It is reported that the HA, PB2, PA
and NS genes of 2009/H1N1 are in the classical swine
lineage derived from the 1918 Spanish pandemic virus,
and many viral mutations associated with the pathogen-
icity and cross-species transmission of 2009/H1N1 are
present in these viral proteins, e.g., D222G in HA [36],
T271A in PB2 [37], T552S in PA [38] and E125D in NS1
[39]. Interestingly, in our study, F9/10 had a D222G sub-
stitution in HA protein which was absent in other 2009/
H1N1 pig isolates submitted to GenBank except the strain
of A/swine/Hong Kong/189/2010. Whether the above
substitutions in the pig isolates play significant roles in
pathogenesis or cross-species transmission, and what
these mutations represent in pigs need to be uncovered by
ongoing studies. Therefore, the occurrence of possible
virulence markers warrant the need for continued system-
atic surveillance of novel influenza viruses.
In conclusion, since pigs play a significant role in the
evolution of influenza viruses and the generation of
more virulent variants, more attention should be paid to
human-to-animal transmission, even possibly animal-
to-human transmission of 2009/H1N1 virus, especially
in events involving pig herds.Additional file
Additional file 1: Lung pathology in BALB/c mice infected with
different H1N1/2009 viruses. The formalin-preserved lung samples of
mice infected with the four H1N1/2009 pig isolates (3/10, F9/10, 5/10 and
6/10), a human isolate designed LN/09 and control mice wereembedded in paraffin and sectioned on 3, 5 and 7 dpi. Serial 4-mm
sections were stained with Hematoxylin and Eosin (H&E), and examined
for pathological changes that corresponded to infection. Images were
obtained on an Olympus BX-50 light microscope at 10-fold original
magnifications (10×).
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